Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction
Retrospective study update evaluating the use of AlloMend Acellular Dermal Matrix (ADM) allograft in pre-pectoral breast reconstruction foll…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel [Phase 3]
Phase 3 clinical trial evaluating a combination of trastuzumab, HS627, pertuzumab, and docetaxel for breast cancer.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) [NA]
A clinical trial is investigating whether resistance and aerobic exercise can help prevent breast cancer in women with dense breasts; recrui…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC [Phase 3]
Phase 3 trial evaluating adjuvant elacestrant versus standard endocrine therapy in high-risk ER+/HER2- breast cancer is currently not recrui…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study [Phase 2]
Phase 2 exploratory trial evaluating hetrombopag to prevent chemotherapy-induced thrombocytopenia in breast cancer patients, conducted in du…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy [Phase 2]
This is a Phase 2 clinical trial update for ASHBY, an accelerated super-hypofractionated breast brachytherapy study sponsored by Virginia Co…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia [NA]
A clinical trial is underway to evaluate opioid-free anesthesia to reduce persistent postmastectomy pain in breast cancer patients; the stud…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors [NA]
A study is evaluating transcranial magnetic stimulation for chemotherapy-induced peripheral neuropathy in breast and gynecologic cancer surv…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study [NA]
The EMPOWER study is a University of Utah-sponsored trial to enhance mammography programs through outreach, wellness, education, and resourc…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer [Phase 1]
This update describes a Phase 1 study evaluating the combination of veliparib and carboplatin in patients with HER2-negative metastatic brea…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: HIIT Following Breast Cancer Chemotherapy [NA]
This clinical trial update describes a study assessing high-intensity interval training after chemotherapy in breast cancer patients. Recrui…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Multicenter Phase III Clinical Study and Translational Research on Adaptive Neoadjuvant Therapy of De-escalation and Escalation for HER2-Positive Breast Cancer Based on Multi-Omics Response Evaluation Model [Phase 3]
A multicenter Phase III trial protocol evaluating adaptive neoadjuvant therapy (de-escalation and escalation) for HER2-positive breast cance…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure [Phase 2]
A Phase 2 trial is investigating whether adding carvedilol to trastuzumab in breast cancer patients can lower the risk of developing heart f…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer [Phase 2]
A Phase 2 trial evaluating eribulin with or without a trastuzumab biosimilar in patients with HER2-overexpressing recurrent or stage IV brea…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC
This trial evaluates HER2-PET imaging as a precision tool to guide treatment with a HER2-targeted antibody-drug conjugate in metastatic brea…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer [Phase 2]
Phase 2 trial update exploring a chemotherapy-free, pCR-guided strategy using trastuzumab, pertuzumab, and T-DM1 in HER2-positive early brea…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Estradiol Plus Olaparib for Breast Cancer (PHOEBE) [Phase 1]
A Phase 1 clinical trial (PHOEBE) is testing estradiol in combination with olaparib for metastatic breast cancer and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer [NA]
This entry reports on an ongoing clinical trial evaluating individual sensitivity to chemotherapy-induced gonadotoxicity in young patients w…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer [Phase 2]
A Phase 2 sustainable and efficient platform trial for developing therapies in early breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors [NA]
An update on an ongoing study testing a mobile health physical activity program with mindful awareness lessons for breast cancer survivors. …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer [Phase 4]
Phase 4 clinical trial update evaluating harms and benefits of endocrine therapy in patients aged 70 and older with lower-risk breast cancer…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR [NA]
This clinical trial update describes a study evaluating drain removal on postoperative safety and patient satisfaction in R-E-NSM with prepe…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients [NA]
This ClinicalTrials.gov update describes a cohort study investigating the combination of cryoablation and thermal ablation as a non-surgical…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. [NA]
MD Anderson Cancer Center is recruiting for a study to identify underserved Texans at hereditary cancer risk using mobile mammography units …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction [NA]
This clinical trial update outlines a planned study at Beaumont Hospital to evaluate well-being and patient-reported outcomes after robotic …